The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case Example. [electronic resource]
- The Annals of pharmacotherapy Feb 2011
- 263-75 p. digital
Publication Type: Journal Article; Review
1542-6270
10.1345/aph.1P496 doi
Antineoplastic Agents--pharmacokinetics Carcinoma, Non-Small-Cell Lung--drug therapy Clinical Trials, Phase III as Topic Drug Resistance, Neoplasm ErbB Receptors--antagonists & inhibitors Gefitinib Humans Lung Neoplasms--drug therapy Mutation Prospective Studies Quinazolines--pharmacokinetics Retrospective Studies Risk Assessment Technology Transfer